Prelude Capital Management’s Opko Health OPK Stock Holding History

Prelude Capital Management’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-133,586	Closed	-$326K	–	1948
2019 Q2	$326K	Buy	+133,586	New	+$291K	0.02%	587
2018 Q3	–	Sell	-196,400	Closed	-$923K	–	1962
2018 Q2	$923K	Buy	196,400 +140,843	+254%	+$534K	0.06%	353
2018 Q1	$176K	Buy	+55,557	New	+$224K	0.01%	710
2015 Q3	–	Sell	-6,050	Closed	-$97K	–	1700
2015 Q2	$97K	Buy	+6,050	New	+$94.1K	0.01%	896

Other funds holding OPK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Prelude Capital Management's OPK Position: Q3 2019 in Review

Prelude Capital Management sold out of Opko Health (OPK) in Q3 2019, closing a stake of 133,586 shares — an estimated $326K sold.

Prelude Capital Management first reported a position in OPK in Q2 2015 and held it in 4 quarters. The position peaked at $923K in Q2 2018. 187 funds tracked by Wall St. Rank hold OPK as of Q3 2019.

Prelude Capital Management reported no remaining Opko Health position as of Q3 2019 after selling out during the quarter.
Prelude Capital Management sold 133,586 Opko Health shares in Q3 2019, an estimated $326K.
Prelude Capital Management first reported a position in Opko Health in Q2 2015 and held it in 4 quarters.
Prelude Capital Management's Opko Health position peaked at $923K in Q2 2018.
187 funds tracked by Wall St. Rank held Opko Health as of Q3 2019.

Based on Prelude Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.